Trials / Completed
CompletedNCT04755985
A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132
A Randomized, Open Label, Multi Dose, Cross Over Design Clinical Study to Evaluate the Pharmacokinetic Pharmacodynamic Characteristics and Safety of AD-213-B and AD-2132 After Oral Administration in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-B to AD-2132 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-213-B | 1 tablet administered before the breakfast during 5 days |
| DRUG | AD-2132 | 1 tablet administered before the breakfast during 5 days |
Timeline
- Start date
- 2021-03-21
- Primary completion
- 2021-05-13
- Completion
- 2021-07-23
- First posted
- 2021-02-16
- Last updated
- 2021-08-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04755985. Inclusion in this directory is not an endorsement.